Evidence map›Paper›PMID 28092092›Full record

ArticleJIMD reports2017

Domains of Daily Physical Activity in Children with Mitochondrial Disease: A 3D Accelerometry Approach.

Saskia Koene, Ilse Dirks, Esmee van Mierlo, Pascal R de Vries, Anjo J W M Janssen, Jan A M Smeitink, Arjen Bergsma, Hans Essers, Kenneth Meijer, Imelda J M de Groot

Open access · greenAbstract read
In one paragraph

Article in JIMD reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Saskia KoeneDepartment of Paediatrics, Radboud Center for Mitochondrial Medicine (RCMM), Radboud University Medical Center, PO BOX 9101, Geert Grooteplein 10, Nijmegen, 6500 HB, The Netherlands. Saskia.koene@radboudumc.nl.
Ilse DirksDepartment of Paediatrics, Radboud Center for Mitochondrial Medicine (RCMM), Radboud University Medical Center, PO BOX 9101, Geert Grooteplein 10, Nijmegen, 6500 HB, The Netherlands.
Esmee van MierloDepartment of Paediatrics, Radboud Center for Mitochondrial Medicine (RCMM), Radboud University Medical Center, PO BOX 9101, Geert Grooteplein 10, Nijmegen, 6500 HB, The Netherlands.
Pascal R de VriesDepartment of Paediatrics, Radboud Center for Mitochondrial Medicine (RCMM), Radboud University Medical Center, PO BOX 9101, Geert Grooteplein 10, Nijmegen, 6500 HB, The Netherlands.
Anjo J W M JanssenDonders Center for Neuroscience, Department of Rehabilitation, Pediatric Physical Therapy, Radboud University Medical Center, Nijmegen, The Netherlands.
Jan A M SmeitinkDepartment of Paediatrics, Radboud Center for Mitochondrial Medicine (RCMM), Radboud University Medical Center, PO BOX 9101, Geert Grooteplein 10, Nijmegen, 6500 HB, The Netherlands.
Arjen BergsmaDonders Center for Neuroscience, Department of Rehabilitation, Radboud University Medical Center, Nijmegen, The Netherlands.
Hans EssersDepartment of Human Movement Sciences, Maastricht University Medical Centre, Maastricht, The Netherlands.
Kenneth MeijerDepartment of Human Movement Sciences, Maastricht University Medical Centre, Maastricht, The Netherlands.
Imelda J M de GrootDepartment of Paediatrics, Radboud Center for Mitochondrial Medicine (RCMM), Radboud University Medical Center, PO BOX 9101, Geert Grooteplein 10, Nijmegen, 6500 HB, The Netherlands.
Radboud University Medical Center · NLRadboud University Nijmegen · NLMaastricht University Medical Centre · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Feasible, sensitive and clinically relevant outcome measures are of extreme importance when designing clinical trials. For paediatric mitochondrial disease, no robust end point has been described to date. The aim of this study was to select the domains of daily physical activity, which can be measured by 3D accelerometry, that could serve as sensitive end points in future clinical trials in children with mitochondrial disorders.In this exploratory observational study, 17 patients with mitochondrial disease and 16 age- and sex-matched controls wore 3D accelerometers at the upper leg, upper arm, lower arm and chest during one weekend. Using the raw data obtained by the accelerometers, we calculated the following outcome measures: (1) average amount of counts per hour the sensors were worn; (2) the maximal intensity; (3) the largest area under the curve during 30 min and (4) categorized activities lying, standing or being dynamically active. Measuring physical activity during the whole weekend was practically feasible in all participants. We found good face validity by visually correlating the validation videos and activity diaries to the accelerometer data-graphs. Patients with mitochondrial disorders had significantly lower peak intensity and were resting more, compared to their age- and sex-matched peers.Finally, we suggest domains of physical activity that could be included when measuring daily physical activity in children with mitochondrial disorders, preferably using more user-friendly devices. These include peak activity parameters for the arms (all patients) and legs (ambulatory patients). We recommend using or developing devices that measure these domains of physical activity in future clinical studies.

Indexed as

3D accelerometryChildrenDaily physical activityMitochondrial diseaseOutcome measures

Identifiers

PMID28092092
PMCPMC5680282
OpenAlexW2579072532

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.